For an adult with chronic low‑back pain and radiculopathy unresponsive to NSAIDs and physical therapy, when and how should a lumbar epidural steroid injection be performed, and what are its contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lumbar Epidural Steroid Injections for Chronic Low Back Pain with Radiculopathy

Do not routinely offer lumbar epidural steroid injections for chronic low back pain with radiculopathy that has failed conservative management, as the most recent high-quality evidence strongly recommends against this intervention outside of clinical trials. 1

Critical Guideline Conflict

The 2025 BMJ guideline represents a paradigm shift from previous recommendations. This guideline provides a strong recommendation AGAINST epidural steroid injections for chronic radicular spine pain, stating that "all or nearly all well-informed people would likely not want such interventions" and that "such interventions should therefore not be offered outside of a clinical trial." 1

This directly contradicts older guidelines:

  • The 2022 ASPN guideline gave a strong recommendation IN FAVOR of epidural injections for disc disease, stenosis, and post-surgical syndrome 1
  • The 2021 ASIPP guideline recommended fluoroscopically guided epidural injections with strong evidence for disc herniation 1

The 2025 BMJ guideline should take precedence as it is the most recent, published in the highest-impact journal, and explicitly addresses the methodological flaws of prior consensus-based guidelines that were often authored by interventionalists (who showed 3x more likely positive conclusions than non-interventionalists). 1

Why This Recommendation Changed

The evidence base reveals:

  • Very low certainty of evidence for benefit in chronic radicular pain 1
  • Patients would be "disinclined to receive treatment with an interventional procedure for which there is very low certainty of evidence for benefit" 1
  • Risk of catastrophic harms including paralysis and death, plus moderate harms like deep infection and altered consciousness 1
  • The risk-benefit ratio does not favor intervention when evidence quality is properly assessed 1

Limited Exception: Acute Radiculopathy

The 2025 AAN systematic review found that ESIs probably reduce short-term pain and disability in cervical and lumbar radiculopathies (number needed to treat = 4-6 for short-term outcomes), but effects diminish long-term. 2 This applies primarily to acute radiculopathy, not chronic pain scenarios.

The 2021 ACOEM guideline specifically recommended against lumbar epidural injections for chronic low back pain in the absence of significant radicular symptoms. 1

If Considering ESI Despite Current Evidence

Should you proceed against current best evidence, the technical approach would be:

Technique

  • Fluoroscopic guidance is mandatory for all approaches (interlaminar, transforaminal, or caudal) 3, 4
  • Transforaminal approach provides more targeted delivery to specific nerve roots 4
  • Interlaminar approach is less target-specific but effective for broader distribution 3

Timing Considerations

  • Acute radiculopathy responds better than chronic symptoms 5
  • Improvement may not occur until 6 days post-injection 5
  • Effects are primarily short-term (≤3 months) 2

Absolute Contraindications

  • Active infection (systemic or local)
  • Coagulopathy or anticoagulation that cannot be safely held
  • Patient refusal after informed consent regarding limited evidence

Relative Contraindications

  • Poorly controlled diabetes (steroid effects on glucose)
  • Immunosuppression
  • Allergy to contrast or medications used

Critical Pitfall

Patients with normal or near-normal MRI imaging fare worse with ESI. A 2025 propensity-matched study found that patients with radicular pain but no nerve root compression on MRI had poorer outcomes compared to those with concordant MRI pathology, though differences were not statistically significant for pain outcomes. 6 This suggests ESI should not be offered when imaging does not demonstrate clear nerve root compression.

The Bottom Line

The current standard of care, based on the most recent and rigorous evidence synthesis, is to avoid offering lumbar epidural steroid injections for chronic radicular pain outside of research settings. 1 The evidence shows very low certainty of benefit, potential for serious harm, and patient values that would not support accepting these risks for uncertain minimal benefit. Continue with evidence-based non-pharmacological interventions as recommended by the ACP guideline, including therapeutic exercise, remaining active, and consideration of multidisciplinary pain management approaches that do not involve invasive procedures.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.